Autologous bone marrow stem cell transplantation for treating myocardial infarction in 6 cases. A 4 years follow up

Journal of Clinical Rehabilitative Tissue Engineering Research

Volumn 13, Issue 10, 2009, Pages 1969-1972

  Yang, Shui Xiang ^a   Xu, Jing ^b   Xu, Gui Yu ^a   Dai, Hao Jie ^c   Tian, Jia He ^d  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b CHINESE PLA GENERAL HOSPITAL   (China)

^c Department of Internal Medicine   (China)

^d CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR;

ACUTE HEART INFARCTION; ADULT; AGE DISTRIBUTION; AGED; ANGIOCARDIOGRAPHY; ANTIGEN PURIFICATION; ARTICLE; AUTOLOGOUS BONE MARROW TRANSPLANTATION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BALLOON CATHETER; CD34 SELECTION; CELL CULTURE; CHINA; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY RECANALIZATION; CORONARY STENT; FOLLOW UP; HEART EJECTION FRACTION; HUMAN; INFORMED CONSENT; PERIPHERAL BLOOD MONONUCLEAR CELL; RESTENOSIS; ST SEGMENT ELEVATION; TRANSLUMINAL CORONARY ANGIOPLASTY;

EID: 64149121923     PISSN: 16738225     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Lipinski MJ, Biondi-Zoccai GG, Abbate A, et al. Impact of intracoronary cell therapy on left ventricular function in the setting of acute myocardial infarction: a collaborative systematic review and meta-analysis of controlled clinical trials. J Am Coll Cardiol. 2007;50(18):1761-1767.
2. Schachinger V, Assmus B, Britten MB, et al. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI Trial. J Am Coll Cardiol. 2004;44(8):1690-1699.
3. Yang SX, Chen X, Zhang S, et al. The advancement of stem cell properties and its transplantation to treat acute myocardial infarction. Chin J Cardiac Arrhyth. 2002;6(6):366-374.
4. Yerebakan C, Kaminski A, Liebold A, et al. Safety of intramyocardial stem cell therapy for the ischemic myocardium: results of the Rostock trial after 5-year follow-up. Cell Transplant. 2007;16(9):935-940.
5. Yang SX,Hu DY,Li TC,et al.Report of myocardial infarction treated with autologous marrow stem cell transplantation in 6 cases. Zhongguo Linchuang Kangfu. 2005;9(46):11-13.
6. Kang HJ, Lee HY, Na SH, et al.Differential effect of intracoronary infusion of mobilized peripheral blood stem cells by granulocyte colony-stimulating factor on left ventricular function and remodeling in patients with acute myocardial infarction versus old myocardial infarction: the MAGIC Cell-3-DES randomized, controlled trial. Circulation. 2006;114(1 Suppl):I145-151.
7. Yang SX, Xu GY. When is the best time of stem cell transplantantion for treating acute myocardial infarction. Lingnan Xinxueguanbing Zazhi. 2007;8(1):57-59.
8. Yang SX, Xu GY, Zhao NN. Timing-window and therapeutic effects of s tem cell transplantation: A Meta-analysis. Zhongguo Zuzhi Gongcheng Yanjiu yu Linchuang Kangfu. 2007;11(11):2164-2166.
9. Ince H, Nienaber CA. Granulocyte-colony-stimulating factor in acute myocardial infarction: future perspectives after FIRSTLINE-AMI and REVIVAL-2. Nat Clin Pract Cardiovasc Med. 2007;4Suppl 1:S114-118.